323 related articles for article (PubMed ID: 27045080)
21. Structural Investigation of a Dimeric Variant of Pyruvate Kinase Muscle Isoform 2.
Srivastava D; Razzaghi M; Henzl MT; Dey M
Biochemistry; 2017 Dec; 56(50):6517-6520. PubMed ID: 29182273
[TBL] [Abstract][Full Text] [Related]
22. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
24. AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.
Park YS; Kim DJ; Koo H; Jang SH; You YM; Cho JH; Yang SJ; Yu ES; Jung Y; Lee DC; Kim JA; Park ZY; Park KC; Yeom YI
Oncotarget; 2016 Jul; 7(30):48155-48167. PubMed ID: 27340866
[TBL] [Abstract][Full Text] [Related]
25. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic activation of PKM2 slows lung tumor xenograft growth.
Parnell KM; Foulks JM; Nix RN; Clifford A; Bullough J; Luo B; Senina A; Vollmer D; Liu J; McCarthy V; Xu Y; Saunders M; Liu XH; Pearce S; Wright K; O'Reilly M; McCullar MV; Ho KK; Kanner SB
Mol Cancer Ther; 2013 Aug; 12(8):1453-60. PubMed ID: 23720766
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analyses of the cysteine thiol oxidation of PKM2 reveal the effects of multiple oxidation on cellular oxidative stress response.
Irokawa H; Numasaki S; Kato S; Iwai K; Inose-Maruyama A; Ohdate T; Hwang GW; Toyama T; Watanabe T; Kuge S
Biochem J; 2021 Apr; 478(7):1453-1470. PubMed ID: 33749780
[TBL] [Abstract][Full Text] [Related]
28. iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer.
Li L; Zhu L; Hao B; Gao W; Wang Q; Li K; Wang M; Huang M; Liu Z; Yang Q; Li X; Zhong Z; Huang W; Xiao G; Xu Y; Yao K; Liu Q
Oncotarget; 2017 May; 8(20):33047-33063. PubMed ID: 28380434
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells.
Chu B; Wang J; Wang Y; Yang G
Mol Med Rep; 2015 Sep; 12(3):4358-4363. PubMed ID: 26082202
[TBL] [Abstract][Full Text] [Related]
30. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
[TBL] [Abstract][Full Text] [Related]
31. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
32. Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms.
Liu J; Wu N; Ma L; Liu M; Liu G; Zhang Y; Lin X
PLoS One; 2014; 9(3):e91606. PubMed ID: 24626155
[TBL] [Abstract][Full Text] [Related]
33. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
Amin S; Yang P; Li Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
[TBL] [Abstract][Full Text] [Related]
34. SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth.
Park SH; Ozden O; Liu G; Song HY; Zhu Y; Yan Y; Zou X; Kang HJ; Jiang H; Principe DR; Cha YI; Roh M; Vassilopoulos A; Gius D
Cancer Res; 2016 Jul; 76(13):3802-12. PubMed ID: 27197174
[TBL] [Abstract][Full Text] [Related]
35. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
[TBL] [Abstract][Full Text] [Related]
36. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
[TBL] [Abstract][Full Text] [Related]
37. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
38. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress.
Yang YC; Chien MH; Liu HY; Chang YC; Chen CK; Lee WJ; Kuo TC; Hsiao M; Hua KT; Cheng TY
Cancer Lett; 2018 May; 421():28-40. PubMed ID: 29408265
[TBL] [Abstract][Full Text] [Related]
39. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
[TBL] [Abstract][Full Text] [Related]
40. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
Chaneton B; Gottlieb E
Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
